Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of radiotherapy dose, fractionation and immunotherapeutic partner in a mouse model of HR+ mammary carcinogenesis.
Buqué A, Bloy N, Petroni G, Jiménez-Cortegana C, Sato A, Iribarren C, Yamazaki T, Galassi C, Hensler M, Bhinder B, Guarracino A, Rippon B, Beltran-Visiedo M, Soler-Agesta R, Pannellini T, Fucikova J, Demaria S, Zhou XK, Elemento O, Formenti SC, Galluzzi L. Buqué A, et al. Among authors: fucikova j. J Natl Cancer Inst. 2024 Dec 11:djae329. doi: 10.1093/jnci/djae329. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39661487
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, Enot D, Hensler M, Kremer M, Stoll G, Hu Y, Massa C, Formenti SC, Seliger B, Elemento O, Spisek R, André F, Zitvogel L, Delaloge S, Kroemer G, Galluzzi L. Buqué A, et al. Among authors: fucikova j. Nat Commun. 2020 Jul 30;11(1):3819. doi: 10.1038/s41467-020-17644-0. Nat Commun. 2020. PMID: 32732875 Free PMC article.
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, Enot D, Hensler M, Kremer M, Stoll G, Hu Y, Massa C, Formenti SC, Seliger B, Elemento O, Spisek R, André F, Zitvogel L, Delaloge S, Kroemer G, Galluzzi L. Buqué A, et al. Among authors: fucikova j. Nat Commun. 2020 Sep 17;11(1):4787. doi: 10.1038/s41467-020-18719-8. Nat Commun. 2020. PMID: 32943636 Free PMC article.
Apoptotic caspases cut down the immunogenicity of radiation.
Buqué A, Rodriguez-Ruiz ME, Fucikova J, Galluzzi L. Buqué A, et al. Among authors: fucikova j. Oncoimmunology. 2019 Aug 20;8(11):e1655364. doi: 10.1080/2162402X.2019.1655364. eCollection 2019. Oncoimmunology. 2019. PMID: 31646103 Free PMC article.
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy.
Iribarren K, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Špíšek R, Zitvogel L, Kroemer G, Galluzzi L. Iribarren K, et al. Among authors: fucikova j. Oncoimmunology. 2015 Sep 2;5(3):e1088631. doi: 10.1080/2162402X.2015.1088631. eCollection 2016 Mar. Oncoimmunology. 2015. PMID: 27141345 Free PMC article. Review.
Trial Watch: Immunotherapy plus radiation therapy for oncological indications.
Vacchelli E, Bloy N, Aranda F, Buqué A, Cremer I, Demaria S, Eggermont A, Formenti SC, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Vacchelli E, et al. Among authors: fucikova j. Oncoimmunology. 2016 Jul 25;5(9):e1214790. doi: 10.1080/2162402X.2016.1214790. eCollection 2016. Oncoimmunology. 2016. PMID: 27757313 Free PMC article. Review.
81 results